Ident. | Authors (with country if any) | Title |
---|
000034 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
000075 (2020) |
Tuan M. Nguyen [États-Unis] ; Yang Zhang [États-Unis] ; Pier Paolo Pandolfi [États-Unis] | Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. |
000147 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. |
000152 (2020) |
Mengmeng Li [République populaire de Chine] ; Liang Chen [République populaire de Chine] ; Jingxiao Zhang [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] | The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. |
000166 (2020) |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
000167 (2020) |
Leon Caly [Australie] ; Julian D. Druce [Australie] ; Mike G. Catton [Australie] ; David A. Jans [Australie] ; Kylie M. Wagstaff [Australie] | The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. |
000184 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
000194 (2020) |
Mahmoud Al-Balas [Jordanie] ; Hasan Ibrahim Al-Balas [Jordanie] ; Hamzeh Al-Balas [Jordanie] | Surgery during the COVID-19 pandemic: A comprehensive overview and perioperative care |
000195 (2020) |
Denis C. Bauer [Australie] ; Aidan P. Tay [Australie] ; Laurence O W. Wilson [Australie] ; Daniel Reti [Australie] ; Cameron Hosking [Australie] ; Alexander J. Mcauley [Australie] ; Elizabeth Pharo [Australie] ; Shawn Todd [Australie] ; Vicky Stevens [Australie] ; Matthew J. Neave [Australie] ; Mary Tachedjian [Australie] ; Trevor W. Drew [Australie] ; S S Vasan [Australie] | Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak. |
000201 (2020) |
Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde] | Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). |
000223 (2020) |
Furong Qi [République populaire de Chine] ; Shen Qian [République populaire de Chine] ; Shuye Zhang [République populaire de Chine] ; Zheng Zhang [République populaire de Chine] | Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses |
000239 (2020) |
Le Chang ; Lei Zhao ; Huafei Gong ; Lunan Wang ; Lan Wang | Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations. |
000257 (2020) |
Alice Lippi [Allemagne] ; Renato Domingues [Allemagne] ; Cristian Setz [Allemagne] ; Tiago F. Outeiro [Allemagne] ; Anita Krisko [Allemagne] | SARS-CoV-2: at the crossroad between aging and neurodegeneration. |
000263 (2020) |
Soeren Lukassen [Allemagne] ; Robert Lorenz Chua [Allemagne] ; Timo Trefzer [Allemagne] ; Nicolas C. Kahn [Allemagne] ; Marc A. Schneider [Allemagne] ; Thomas Muley [Allemagne] ; Hauke Winter [Allemagne] ; Michael Meister [Allemagne] ; Carmen Veith [Allemagne] ; Agnes W. Boots [Pays-Bas] ; Bianca P. Hennig [Allemagne] ; Michael Kreuter [Allemagne] ; Christian Conrad [Allemagne] ; Roland Eils [Allemagne] | SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. |
000264 (2020) |
Soeren Lukassen [Allemagne] ; Robert Lorenz Chua [Allemagne] ; Timo Trefzer [Allemagne] ; Nicolas C. Kahn [Allemagne] ; Marc A. Schneider [Allemagne] ; Thomas Muley [Allemagne] ; Hauke Winter [Allemagne] ; Michael Meister [Allemagne] ; Carmen Veith [Allemagne] ; Agnes W. Boots [Pays-Bas] ; Bianca P. Hennig [Allemagne] ; Michael Kreuter [Allemagne] ; Christian Conrad [Allemagne] ; Roland Eils [Allemagne] | SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. |
000279 (2020) |
Jie Wang ; Haiting Feng [République populaire de Chine] ; Sheng Zhang [République populaire de Chine] ; Zuowei Ni [République populaire de Chine] ; Lingmei Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Lixin Zhuo ; Zifeng Zhong [République populaire de Chine] ; Tingting Qu [République populaire de Chine] | SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital. |
000297 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
000314 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
000317 (2020) |
Ashleigh Shannon [France] ; Nhung Thi Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [États-Unis, France] ; Francois Ferron [France] ; Bruno Canard [France] | Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites |
000319 (2020) |
Dabiao Chen [République populaire de Chine] ; Wenxiong Xu [République populaire de Chine] ; Ziying Lei [République populaire de Chine] ; Zhanlian Huang [République populaire de Chine] ; Jing Liu [République populaire de Chine] ; Zhiliang Gao [République populaire de Chine] ; Liang Peng [République populaire de Chine] | Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |
000323 (2020) |
| Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18). |